Pharmaceutical

Repligen Corporation to Present at Wells Fargo Healthcare Conference

WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership,…

1 year ago

10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

PLEASANTON, Calif., Aug. 22, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology,…

1 year ago

Near-Infrared (NIR) Spectroscopy Market size is set to grow by USD 698.9 million from 2024-2028, Rising food safety concerns to boost the market growth, Technavio

NEW YORK, Aug. 22, 2024 /PRNewswire/ -- The global near-infrared (NIR) spectroscopy market  size is estimated to grow by USD…

1 year ago

Love A Wholistic Life Launches Nutritional Weight Loss Courses

Premier Plant-Based Nutrition Program and Coaching Service Announces Sustainable Wellness Through Comprehensive Nutrition and Lifestyle Guidance LOS ANGELES, Aug. 22,…

1 year ago

Ubie Announces Social Impact Framework, Shows Estimated Patient Life Expectancy Impact of 27,000 Years and Approximately $1BN

Ubie has taken the lead in implementing a new standard of measurement to evaluate health and economic impact for global…

1 year ago

Two New FDA-Clearances for Sibel Health Enables Compatibility of Advanced Wearable Sensors to 3rd Party Software Solutions

CHICAGO, Aug. 22, 2024 /PRNewswire/ -- Sibel Health announces two additional FDA-clearances enabling its advanced wearable sensors to operate with compatible…

1 year ago

Alkem MedTech enters into a landmark agreement with Exactech for manufacturing and marketing knee and hip replacement implants in India

MUMBAI, India, Aug. 22, 2024 /PRNewswire/ -- Alkem MedTech Pvt Ltd ("Alkem MedTech"), a wholly-owned subsidiary of Alkem Laboratories Ltd…

1 year ago

Evogene Reports Second Quarter 2024 Financial Results

Conference call and webcast: today, August 22, 2024, 9:00 am ET Financial and Business Highlights: H1 2024 revenues $5.1M, up…

1 year ago

NervGen Pharma Reports Q2 2024 Financial Results and Operational Updates

Targeting to complete enrollment in the Phase 1b/2a chronic cohort in Q3 2024Protocol being amended to enhance enrollment and lessen…

1 year ago